Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Mannitol started as a sweet solution—a basic sugar alcohol first isolated in the early 19th century from the exudates of the flowering ash. Early pharmacists discovered it in medicinal plants like seaweed and mushrooms, turning crude extracts into a valuable medical substance. In the 1960s, clinicians began turning to mannitol for its osmotic powers. It quickly gained attention among neurologists treating cerebral edema and nephrologists facing cases of acute kidney injury. The 1970s and 80s brought rigorous trials and the substance settled into injection vials under strict pharmaceutical standards like BP, EP, and USP grades. These standards ensured that mannitol met safety, purity, and performance expectations, which proved essential as the injectable form became widespread in intensive care, surgery, and nephrology circles worldwide.
Today, mannitol for injection arrives as a sterile, non-pyrogenic solution. Pharmacists keep it ready in different vial sizes or flexible bags to suit hospital routines. I’ve handled the colorless solution countless times, matching concentrations to the patient’s weight and clinical need. Packagers label every lot with the BP, EP, and USP grade, so buyers at hospitals and clinics don’t second guess its quality. Strict batch records follow the drug from raw sugar extraction, through crystallization, to sterilization and final inspection. The result is a heavy-duty osmotic agent trusted for rapid clinical decisions where minutes can save brain cells or kidneys.
Mannitol stands out for its sheer stability. It comes as white, odorless crystals or a granular powder that dissolves easily in water. It’s got a molecular weight of 182.17, with the chemical formula C6H14O6. The solubility reaches 22 grams per 100 mL of water at room temperature, enough to make concentrated infusions. The pH of its injectable forms sits between 5.0 and 7.0. It doesn’t easily oxidize or degrade under normal storage—pharmacists profit from long shelf lives when refrigeration space is limited. Nurses rarely suffer with clogs or precipitation, and the solution moves smoothly through IV lines, helping deliver rapid relief during neurological emergencies.
Labels for pharma-grade mannitol lay it all out: strength (commonly 10%, 15%, or 20%), lot number, expiration, manufacturer, and serial controls required by international authorities. Each batch lists testing data—residue on ignition, clarity, identification, and bacterial endotoxins—so hospital buyers can compare certificates of analysis. Facilities demand traceability, and labels must match the drug master file on record with regulatory bodies. Instructions highlight storage at controlled temperatures (between 15–25°C) and the need to check for precipitation before use. Even the barcodes translate into global tracking databases—traceability isn’t a future fantasy, it’s standard protocol today.
Manufacturers follow a timetable of extraction, purification, concentration, and sterilization. The feedstock—corn, wheat, or potato starch—gets processed into glucose, then hydrogenated under pressure. Nickel catalysts push the reaction and churn out crude mannitol and sorbitol. Filtration, fractional crystallization, and decolorization separate mannitol from sibling polyols. Pharmaceutical-grade crystallization steps trim away impurities. Autoclaves or membrane filters guarantee sterility, then filling machines pour the solution into pyrogen-free vials or bags under tight environmental controls. Workers test samples throughout the process—one incomplete wash or filter change and the batch won’t see a hospital shelf.
In the lab, mannitol acts as a reliable platform for further chemical tweaks. Chemists oxidize it to form mannose or other simple sugars. Special catalysts can shift its ring form or introduce esters for more exotic uses. In industry, its chemical inertia makes it a common excipient in tablets and lyophilized drug formulations. Some labs explore conjugates for targeted drug delivery and new routines for converting mannitol into carbon-rich nanomaterials. Researchers keep an eye on these pathways, hoping they’ll unlock safer, site-specific drugs or smarter packaging for fragile biologics.
You might see mannitol discussed under several names: D-Mannitol, Mannite, Osmitrol, and many more. On pharmacy shelves, different brands or generic names often signal the same high-purity substance. The enzyme mannitol dehydrogenase refers to its role in metabolism. In the industrial world, “mannite” crops up in food-grade discussions. The pharma sector locks in on BP, EP, and USP grade monographs to ensure every vial matches reference properties set by international authorities—synonyms might crop up, but the substance at the heart remains strictly defined.
Health agencies write thick manuals for the safe handling of injectable mannitol. Vials and bags face inspection under Good Manufacturing Practices (GMP). Facilities train teams to recognize and act on precipitation, crystallization, or contamination. Nurses and pharmacists wear gloves and check lot codes before spiking any solution. In use, rapid IV infusion of concentrated mannitol can push patients toward electrolyte shifts or even acute renal failure, so protocols demand careful monitoring. Administrators track adverse events and recall data, with labs ready to retest vials when signals suggest a contamination. National agencies and the World Health Organization update safety protocols as new data comes in—no one leaves standards to guesswork.
In hospitals, mannitol sits on the crash cart for brain swelling, acute glaucoma, and certain kidney conditions. Neurosurgeons look for fast-acting hyperosmolar agents—mannitol fits the bill, reducing intracranial pressure by pulling fluid from brain tissue into the vascular space. Ophthalmologists rely on it before eye surgeries to shrink swollen tissues and clear the visual field. Intensive care teams use mannitol to help start or maintain urine flow in select cases of oliguric states—though its use there now faces strict review. Beyond medicine, you’ll find mannitol stabilizing lyophilized vaccines, reducing tablet friability, and keeping sensitive biologics dry for shipping. Its sweet flavor and low glycemic load earn it space in food industries, but Pharma Grade vials stay rigorously separated from these uses.
Research keeps mannitol in innovation’s spotlight. University studies examine its value in delivering drugs past the blood-brain barrier—where very few drugs can sneak through. Some teams work on “mannitol-based conjugates” to target brain tumors or slow-growing infections. Scientists analyze osmotic agents in medical imaging to open tight cellular barriers for better diagnostics. At pharmaceutical companies, development scientists refine mannitol crystals to pack more potency into smaller vials and lengthen stability on distant clinic shelves. Clinical trials explore new dosing protocols to balance efficacy with risks, looking for sweet spots that lower adverse event rates. Even packaging upgrades—like multi-layered infusion bags that block light and prevent leaching—get tested and retested before rollout.
Toxicologists take mannitol’s safety record seriously. At high doses, especially in patients with renal impairment or compromised blood-brain barriers, mannitol can backfire. Studies from the 1980s and 90s documented rare cases of acute kidney injury and hyperkalemia. Modern toxicity panels layer on new endpoints: genetic toxicity, reproductive health, and long-term metabolic effects. Regulatory bodies like the FDA and EMA regularly comb through global adverse event reports, updating recommendations for high-risk patients. Researchers design animal studies and cell assays to confirm that acute and chronic toxic risks remain manageable in routine clinical use. Drug safety teams gather post-marketing surveillance in hospitals worldwide to respond quickly if new risks emerge.
The future for injectable mannitol looks promising, but not without challenges. Researchers want more personalized protocols—matching dose and rate to a patient’s genetics, age, and pre-existing conditions. Digital health records and AI-assisted dosing tools may soon make this possible, cutting down on human error. In drug delivery, mannitol-based nanostructures might help shuttle cancer drugs right to tumors or bypass stubborn biological barriers. Green chemistry could reinvent its production, cutting waste and using enzymes instead of nickel catalysts. Supply chains demand greater transparency, so fully trackable systems linking crops to vials become real possibilities. On the front lines, clinicians continue to demand new safety data and smarter packaging. Every breakthrough shapes the conversation around osmotic agents and keeps patients at the center of progress.
Hospitals rely on mannitol as an injectable solution for treating a range of critical issues. In emergency rooms, doctors pick mannitol to help patients with high pressure inside the skull or eyes. You see a head injury on the news, or someone comes in after a stroke—there’s a good chance mannitol gets a mention on the care plan. Mannitol draws fluid out of tissues and into the bloodstream so the body can clear it through the kidneys. For me, seeing patients come in with severe swelling in the brain after trauma and watching that pressure drop with the help of mannitol confirms its importance. It's especially useful because some drugs struggle to cross the blood-brain barrier, but mannitol keeps on working in those moments when seconds matter.
Mannitol often steps in for kidney support during major surgeries. Surgeons and nephrologists turn to it if there’s a risk that the kidneys might shut down. After all the research and trials over the years, the main idea remains the same—mannitol forces more urine production, essentially flushing out toxins and keeping blood flowing to the kidneys. In the operating room, mannitol serves as an old reliable friend that can help lower the risk of acute renal failure.
Pharma grade mannitol means strict standards—BP (British Pharmacopoeia), EP (European Pharmacopoeia), or USP (United States Pharmacopeia). Meeting these quality levels is not just about ticking boxes on a form. It gives doctors and patients confidence that what goes into the IV bag meets international expectations for purity and safety. Hospitals pay close attention to this, and rightly so. Unsafe mannitol could mean contaminants or improper concentration, putting already vulnerable patients at greater risk.
No medication is perfect, and mannitol is no exception. Too much fluid pulled out of tissues too fast can strain the heart, especially in older adults or those with weak hearts. Using mannitol requires careful monitoring of vital signs, kidney output, and electrolytes. Nurses and pharmacists check lab results hour by hour, and any changes in heartbeat or swelling get attention right away. Years of experience have shown that adjusting the dose and drip rates, plus close team communication, keep most complications in check.
People often overlook the behind-the-scenes work involved in bringing a reliable drug into a hospital. Every manufacturer batch gets tracked, and every dose is matched to the right patient by pharmacists and nurses who’ve seen what happens when shortcuts get taken. The push for consistent pharma grade standards isn’t just red tape—it’s central to making sure patients don’t get sicker from the treatments themselves. As shortages of certain IV drugs hit headlines, professionals realize just how interconnected the supply chain is.
Research into mannitol keeps moving. Scientists are testing new ways to make the solution safer and more convenient for doctors and patients. Advances in packaging, sterile preparation, and dose tracking aim to reduce infection risks and pinpoint side effects before trouble starts. In my view, this ongoing work brings hope for fewer medical errors and safer outcomes, while keeping costs manageable for healthcare systems.
Figuring out how much mannitol to use in a hospital setting never feels like a game of guesswork. Doctors walk a careful line, aiming to help while avoiding harm. In my own years working alongside healthcare teams, I’ve seen the value in sticking to clear numbers, especially with drugs like mannitol. The usual intravenous dose lands around 0.25 to 2 grams per kilogram of body weight. That means an adult weighing 70 kilos can expect somewhere between 17.5 and 140 grams, depending on what the body is up against. Kidney problems, brain swelling, or increased eye pressure all call for different protocols. No one-size-fits-all answer covers every case.
Giving mannitol through an IV isn’t about convenience. Oral use doesn't cut it because the gut just won’t absorb this sugar alcohol the way the bloodstream can. In the hospitals where I’ve worked, nurses hang a bag, set a calculated drip rate, and keep an eye out for trouble. That’s not busywork — that vigilance keeps things safe. The solution often comes in 5%, 10%, or 20% concentrations, mixed just before use, kept away from light and heat to prevent odd crystals from forming in the bag. Any visible crystals mean a new bag gets started. Safety matters more than saving supplies.
I’ve watched the side effects of mannitol firsthand. Speeding or slowing the drip can cause headaches, a racing heart, dehydration, or worse. Kidney function always gets another look before a doctor gives the go-ahead. Anyone with compromised kidneys faces bigger risks. In places where staff knows how to look for red flags — changes in blood pressure, signs of fluid overload, lung crackles on auscultation — outcomes get better. Complacency leads to missed complications, something I never want to see unfold again.
The clear instructions that come with mannitol draw on long years of clinical research and regulatory approval. United States Pharmacopeia standards shape how pharmacists reconstitute and label these drugs. Groups like the U.S. Food and Drug Administration go over reams of safety data before signing off. Hospitals then set up protocols based on these standards, sending reminders through electronic health records and staff briefings. I’ve sat through those meetings; I’ve watched how strict adherence to protocols ends up saving lives during high-stress cases.
Mistakes can happen in busy wards. Nurses have a heavy workload and even a small lapse can cause trouble. What helps most: regular training, double-checking calculations, and having a second set of eyes on the IV bags and patient charts. Electronic medication records work best when staff trust them and use them right. In places where everyone owns up to mistakes early, systems evolve instead of covering things up. A culture that encourages learning from every close call does more to keep people healthy than any high-tech software ever could.
Patients who ask questions and get clear answers about what goes into their IV drip feel more confident in their care. Transparency builds trust. I’ve seen families stay calmer when nurses patiently explain why these drugs are needed, what signs to watch for, and how everyone on the team will keep monitoring. The trust built here helps patients recover faster and supports the kind of care we all want to see in hospitals everywhere.
Mannitol shows up in hospital pharmacies every single day. Anyone who has ever prepared it for injection knows how moisture creeps into every corner if you give it a chance. Dry mannitol stands up well on its own, but once exposed to damp air, this ingredient starts clumping and loses that free-flowing feel that mixers and injectors count on. That is just one reason proper storage is not just a good idea—it’s a requirement if you want to keep product quality and patient safety front and center.
Shelves rarely do all the work. A storage room for mannitol should stay cool—usually below 25°C. I have seen storerooms where basements hit summer heat, and mannitol caked up in a week. Dry places matter more than people think. Mannitol sucks up water from the air, losing its texture and making measurement a headache. Too much moisture can also foster microbial growth, so running a dehumidifier or keeping stock in climate-controlled facilities never feels optional. In practice, tossing a few silica gel packets into bulk containers makes a world of difference. Pharmacy staff rely on well-sealed packaging and often double-bag opened containers, especially if their storage space gets humid or drafty.
Clear labeling and sturdy packaging prevent costly mistakes and maintain trust with the team. Only original, tamper-evident containers with intact seals or closures earn a spot on pharmaceutical shelves. Once you break that primary seal, use the contents promptly and keep the lid tightly shut between uses. Using unlabelled jars or hastily-repurposed bags ends with contamination scares, measurement mistakes, and lots of wasted product. These lessons stick after seeing just a small spill compromise an entire shelf’s worth of stock.
Word travels fast if someone skips gloves or ignores the hand-washing sink when preparing a batch. Any powder for injection, especially mannitol, benefits from staff who see sterility and hygiene as part of their routine, not as an annoying rule. Dispensers and weighing stations should stay clean, free of wet residues. Wiping with 70% isopropyl alcohol after each session gives a line of defense against microbial contamination. I learned early on to avoid reusing scoops or spatulas without a thorough clean, as even trace residues can change how mannitol dissolves or behaves.
Expired mannitol loses more than shelf life. Old stock may not dissolve as expected or could even grow mold if kept improperly, something I’ve seen happen in poorly managed storerooms. A clear system—recording dates, rotating stock (oldest out first), and tracking use—keeps everything fresh and ready. Disposing expired or contaminated stock must follow local rules, keeping it away from public water supplies and regular trash. Staff training often covers these protocols in the first week, but reminders never hurt, especially in busy clinics or crowded pharmacies.
No hospital, clinic, or compounding pharmacy wants to answer for compromised medications. The small steps—control the temperature, keep everything dry, seal containers tight, clean tools every time—allow staff to focus on patient care without distractions or unnecessary risks. Having seen the headache caused by a single clumpy jar or mislabelled bag, it is clear why strict, commonsense storage and handling stand at the top of every pharmacist’s checklist.
Mannitol hits hospital shelves as a crucial medicine for some serious conditions. Doctors use it to lower pressure inside the skull, bring down swelling in the brain, and help kidneys flush out toxins. A nurse once told me, “This drug can work like magic, but only if you use it the right way.” The benefits are real, but so are the risks of ignoring key precautions.
Give mannitol too quickly, and things can spiral fast. Mannitol pulls water from tissues into the blood, which means bodies dealing with heart or lung problems struggle. Overload the bloodstream, and the heart might not keep up. Extra fluid winds up in the lungs or feet, which paves the way for heart failure or breathing trouble. From experience, ER doctors rely on heart and lung checks before hanging that mannitol bag on the IV pole. Blood pressure and heart rate need close attention, especially in older patients or those frail from illness. More than one life has been saved simply by holding off mannitol for a weak heart.
Some people just can’t tolerate mannitol. Folks with severe kidney disease, no urine output, or brain bleeding outside of surgery face real danger. Mannitol can’t leave the body if kidneys aren’t working—leading to growing swelling instead of relief. Hospital protocols flag these patients quickly. Those with severe dehydration get sicker with mannitol, not better. Giving it dries tissues out even more. Doctors keep a patient’s hydration status at the front of their minds for this reason, often ordering blood work before starting treatment.
Mannitol changes the balance of salts in the body. Blood sodium and potassium shift and take tolls on nerves, muscles, and the heart. If you ask a nephrologist, they’ll tell you about cases where rapid sodium changes have left patients in worse shape than before. Some hospitals schedule lab tests every few hours during treatment. This helps doctors tweak doses and avoid nasty side effects, including confusion, weak muscles, or dangerous heart rhythms.
Though rare, severe allergic reactions happen. Symptoms can include rash, itching, or trouble breathing. Hospitals keep emergency gear close, especially during the first dose. Staff pay extra attention to anyone who has had reactions to medicines in the past. In these moments, experience trumps theory—a team’s quick response saves lives.
Clear guidelines set up a safer experience for both patients and medical teams. Many look to detailed checklists: Who has kidney disease? Who recently had head trauma? Are kidneys filtering properly? Simple but disciplined screening helps target who benefits, and who risks real harm. Education stands just as tall as technology here. Training sessions remind staff to never let routine become careless when setting up mannitol drips.
Cross-team communication plays a huge role. Pharmacists, doctors, and nurses stay in the loop together, each watching for the early warning signs: low blood pressure, growing swelling, or new confusion. If teams act fast, many complications can be stopped in their tracks. For families and patients, speaking up about previous kidney trouble, allergies, or past reactions can prevent disaster before treatment even starts.
Mannitol stands as one of the truly powerful tools in modern medicine, but it offers no shortcuts if skipped precautions or overlooked patient risks enter the picture. Real experience, ongoing checks, and honest teamwork create the safety net that keeps mannitol both potent and safe in medical hands.
Mannitol’s been around for decades. Hospitals rely on it for conditions like brain swelling or kidney failure. Doctors count on its power to pull extra fluid out of the body where fluid poses a real danger. Still, this medicine has real risks sticking alongside the benefits. Being on the receiving end often feels less like a power boost and more like a wild ride, especially if you’re not prepared for the bumps.
If you’ve watched someone take mannitol, the first sign things aren’t going right often comes through the veins. The solution feels cold going in, sometimes stings or burns. Shortly after the drip starts, people feel a rush to use the bathroom. That’s no surprise since mannitol basically turns up the kidneys and gets them flushing fluid quickly. Too much urination brings obvious trouble: fast dehydration. People may start to crave water, feel lightheaded, or notice a racing pulse. I’ve seen confusion sneaking up on people, especially older patients. It rarely hits like a thunderclap—it’s more like a slow fog rolling in. The brain dries out just enough to lose track of details, names, even where that hospital bed sits in the building.
Some people notice headaches, nausea, and vomiting. Those sound minor unless you realize treatments already wear patients thin. Each new side effect feels like adding something heavy to an already full plate. I've met folks who described chest pain or palpitations after the infusion started, their stress going up as their body reacted to the changes in fluid.
It’s not just about feeling mildly off. Mannitol can swing electrolytes out of normal ranges. Sodium drops too low, potassium swings up or down, and suddenly a person goes from just a little weak to unable to move properly. In the ICU, I’ve seen people develop muscle cramps, twitching, or even heart rhythm problems—sometimes life-threatening—because their blood chemistry shifted too quickly.
Allergic reactions do happen, though rarely. Red, splotchy skin shows up first, then swelling, sometimes trouble breathing. This doesn’t drag out over days; it happens fast and can turn dangerous in minutes.
Kidneys, already under pressure, sometimes give up with too much mannitol. Renal failure becomes the worst-case scenario, sometimes in people who didn’t seem to have severe kidney issues to start. This isn’t something families expect when they're told treatment will relieve pressure or swelling, so it feels like a betrayal when it occurs.
Clear, honest communication helps. In practice, doctors and nurses run lab tests before and during infusion and adjust the dose to fit real-time results. Replacing lost fluids with the right mix, not just water, helps keep electrolytes balanced. Paying close attention to small symptoms makes a difference—note each complaint, because that's the body’s early warning system.
Listening and observing carefully save more lives than any textbook. Before each dose, patients and caregivers talk through allergies, existing kidney problems, heart issues, or previous reactions to medications. People with more risks get closer monitoring, because side effects tend to hide in plain sight till things get serious. Everyone involved, from families to nurses, has to stay alert to subtle shifts.
| Names | |
| Preferred IUPAC name | (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol |
| Other names |
D-Mannitol Mannite Osmitrol Mannitolum |
| Pronunciation | /ˈmæn.ɪ.tɒl/ |
| Identifiers | |
| CAS Number | 69-65-8 |
| 3D model (JSmol) | `3D model (JSmol)` string for Mannitol (for injection) is: ``` C(C(C(C(C(CO)O)O)O)O)O ``` |
| Beilstein Reference | 1723791 |
| ChEBI | CHEBI:16899 |
| ChEMBL | CHEMBL: CHEMBL1201342 |
| ChemSpider | 2157 |
| DrugBank | DB00742 |
| ECHA InfoCard | 03b7812b-bbb5-4e2c-abd2-9d35a5c2e2a7 |
| EC Number | 87-78-5 |
| Gmelin Reference | Gmelin Reference 83464 |
| KEGG | C00792 |
| MeSH | D009348 |
| PubChem CID | 6251 |
| RTECS number | OP2060000 |
| UNII | V4SLZ7R0DV |
| UN number | UN1230 |
| CompTox Dashboard (EPA) | Mannitol (For Injection) BP EP USP Pharma Grade" on the CompTox Dashboard (EPA) corresponds to: **DTXSID1024269** So your requested 'string' is: DTXSID1024269 |
| Properties | |
| Chemical formula | C6H14O6 |
| Molar mass | 182.17 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.52 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -3.1 |
| Vapor pressure | Negligible |
| Acidity (pKa) | Acidity (pKa): 13.5 |
| Basicity (pKb) | 7.4 |
| Magnetic susceptibility (χ) | -9.8 × 10⁻⁶ |
| Refractive index (nD) | 1.333 |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 285.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | –2196 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | –2824 kJ/mol |
| Pharmacology | |
| ATC code | B05BC01 |
| Hazards | |
| Main hazards | May cause irritation to eyes, skin, and respiratory tract |
| GHS labelling | GHS07; Signal Word: Warning; Hazard Statements: H335 May cause respiratory irritation; Precautionary Statements: P261, P271, P304+P340, P312 |
| Pictograms | GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | Not a hazardous substance or mixture. |
| Precautionary statements | Keep container tightly closed. Store in a dry place. Store at room temperature. Avoid contact with eyes, skin, and clothing. Wash thoroughly after handling. Use with adequate ventilation. |
| NFPA 704 (fire diamond) | NFPA 704: 1-0-0 |
| Autoignition temperature | > 430°C |
| Explosive limits | Non-explosive |
| Lethal dose or concentration | LD50 (rat, IV): 7.2 g/kg |
| LD50 (median dose) | about 17-22 g/kg (intravenous, rat) |
| NIOSH | Not Listed |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 3 years |
| IDLH (Immediate danger) | Not Listed |
| Related compounds | |
| Related compounds |
Sorbitol Xylitol D-Mannose Glycerol Isomalt Lactitol Erythritol Arabitol |
Chengguan District, Lanzhou, Gansu, China
